Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it?
Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it?
复制标题
DOI:
10.1007/s00595-009-4253-9
复制
发表时间:
2011-02-01
期刊:
影响因子:
2.5
通讯作者:
Violi, Vincenzo
中科院分区:
文献类型:
--
作者:
Costi, Renato;Di Mauro, Davide;Violi, Vincenzo
Despite the encouraging results of chemotherapy in patients affected by incurable colorectal cancer (CRC), surgical resection of a primitive tumor is still a common approach worldwide. The identification of prognostic factors related to short survival (< 6 months) may allow excluding from resective surgery those who may not benefit from it.A retrospective analysis was performed of 15 variables in a population of 71 patients undergoing nonemergency palliative primary resections of incurable CRC, including patients' demographics and clinical/histopathological characteristics of the tumor.No variables were related to perioperative mortality (8.5% overall). A multivariate analysis revealed that older age (a parts per thousand yen80 years) and metastasis to more than 25% of the lymph nodes were associated with survival (4 and 6 months, respectively). Mucoid adenocarcinoma therefore tends to be associated with the prognosis (P = 0.070).An elderly age tends to be a contraindication to an elective primary tumor resection in patients affected by incurable CRC. Massive lymph node involvement and mucoid adenocarcinoma should also be considered before planning major colonic surgery.